With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

Larry North
Resilience, Reinvention, and the Relentless Pursuit of Growth: Larry North’s Journey from Fitness Icon to Private Equity Leader
February 20, 2026

Entrepreneurship is being glamorized in real time. Social media highlights overnight wins, AI tools promise instant scale, and private equity is reshaping industries at a rapid clip. Yet behind every “success story” is something far less flashy: failure, adaptability, and the discipline to keep going when life hits hard. According to the U.S. Bureau…

Read More
Consulting
Consulting Reframed: Perspective, Leadership, and Impact Beyond the Client
February 19, 2026

As organizations navigate accelerating digital transformation, tighter margins, and increasing organizational complexity, the role of consultants is being re-examined. Today’s most effective consulting leaders are no longer valued simply for delivering projects, but for bringing outside perspective, cross-industry insight, and the ability to lead through ambiguity. Most large organizations today are not short on…

Read More
comedy
Laughter as a Service: How Comedy Can Power Trust, Teamwork, and Career Growth
February 19, 2026

Comedy might be the most underused business skill in your toolkit… In a world of back-to-back Zoom calls, Slack threads, and AI-generated everything, real human connection can start to feel like an afterthought. We’re moving faster than ever, but sometimes we’re listening less, reacting more, and missing the small moments that actually build trust. The…

Read More
founder-led brand
The Art of Evolution: Leading a Founder-Led Brand Into Its Next Chapter with Mary Beth Sheridan
February 19, 2026

For many retail brands, growth today isn’t just about innovation — it’s about keeping pace with customers whose expectations are evolving in real time, led by younger generations who expect brands to reflect their values and show up with cultural relevance. In fact, recent research from MG2 found that the overwhelming majority of Gen Z…

Read More